Cargando…

Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy

Detalles Bibliográficos
Autores principales:	Xu, Yingyang, Guan, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771587/ https://www.ncbi.nlm.nih.gov/pubmed/35079348 http://dx.doi.org/10.1002/clt2.12115

Ejemplares similares

Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study
por: Tat, Tugba S.
Publicado: (2018)

Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
por: Larenas-Linnemann, Désirée Erlinda, et al.
Publicado: (2020)

Cluster subcutaneous allergen immunotherapy as a sustainable practice towards net zero healthcare
por: Domínguez Estirado, Alicia, et al.
Publicado: (2023)

Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling
por: Aue, Adam, et al.
Publicado: (2021)

Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bian, Sainan, et al.
Publicado: (2021)

Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?
por: Wang, Yin, et al.
Publicado: (2023)

Effect of patient and parental anxiety on adherence to subcutaneous allergen immunotherapy during the coronavirus disease 2019 pandemic
por: Kulhas Celik, Ilknur, et al.
Publicado: (2021)

Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections
por: Kim, Laura, et al.
Publicado: (2014)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy
por: Lee, Ji-Ho, et al.
Publicado: (2019)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis
por: Nahm, Dong-Ho, et al.
Publicado: (2016)

Safety and adverse reactions in subcutaneous allergen immunotherapy: a review
por: Incorvaia, Cristoforo, et al.
Publicado: (2023)

Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic
por: Koca Kalkan, Ilkay, et al.
Publicado: (2021)

Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement
por: Taher, Yousef A., et al.
Publicado: (2010)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Impact of subcutaneous specific-allergen immunotherapy in the quality of life of brazilian moderate/severe atopic dermatitis patients
por: Teixeira, Ana Julia, et al.
Publicado: (2015)

Immunotherapy – 2073. Therapeutic effect of mite allergen vaccines by subcutaneous route in allergic Cuban asthmatic patients
por: Almarales, Raúl Lázaro Castro, et al.
Publicado: (2013)

Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life
por: Lee, Sang Pyo, et al.
Publicado: (2018)

Allergic Reactions After the Administration of COVID-19 Vaccines
por: Bian, Sainan, et al.
Publicado: (2022)

Allergen-Specific IgE and IgG4 as Biomarkers for Immunologic Changes during Subcutaneous Allergen Immunotherapy
por: Nikolov, Georgi, et al.
Publicado: (2021)

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
por: Nahm, Dong-Ho, et al.
Publicado: (2012)

Anaphylaxis during specific subcutaneous immunotherapy against ragweed allergen -- case record
por: Prnjavorac, Besim, et al.
Publicado: (2014)

Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
por: Morais-Almeida, Mário, et al.
Publicado: (2016)

Novel vaccines for allergen-specific immunotherapy
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Safety and disease flare of autoimmune inflammatory rheumatic diseases: a large real-world survey on inactivated COVID-19 vaccines
por: Fan, Yong, et al.
Publicado: (2022)

Successful Subcutaneous Allergen-Specific Immunotherapy in Refractory Atopic Keratoconjunctivitis: A Case Report
por: Jongkhajornpong, Passara, et al.
Publicado: (2017)

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis
por: Mösges, Ralph, et al.
Publicado: (2019)

Safety, Efficacy, and Preventive Role of Subcutaneous and Sublingual Allergen Immunotherapy for the Treatment of Pediatric Asthma
por: Giannetti, Arianna, et al.
Publicado: (2020)

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases
por: Fennis, Evelien E. M., et al.
Publicado: (2022)

Uterine Anaphylaxis Due to Subcutaneous Immunotherapy (SCIT) for Inhalant Allergens: A Case Series
por: Ganguli, Malika P, et al.
Publicado: (2023)

Allergen specificity is relevant for immunotherapy prescription in polysensitised children
por: Ciprandi, Giorgio, et al.
Publicado: (2012)

Tablet allergen immunotherapy (TAIT) requires tight management
por: Ciprandi, Giorgio
Publicado: (2021)

Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy
por: Jacobsen, Lars, et al.
Publicado: (2012)

Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Past, present, and future of allergen immunotherapy vaccines
por: Dorofeeva, Yulia, et al.
Publicado: (2020)

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
por: Pfaar, Oliver, et al.
Publicado: (2023)

Cluster Subcutaneous Allergen Specific Immunotherapy for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-Analysis
por: Feng, Shaoyan, et al.
Publicado: (2014)

Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
por: Zhou, Suizi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gem2fjt6smh2q1pplibs9fhjfo